Integrated Cardiac Safety

Integrated Cardiac Safety

International Edition
 
About the Book
The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, government officials, and students.
About the Author: J. Rick Turner, PhD, PGCE, MICR, is Chairman, Department of Clinical Research at Campbell University School of Pharmacy. Dr. Turner has extensive teaching, research, and pharmaceutical credentials and more than a dozen awards and honors, including a Commit to Product Development Award from GlaxoSmithKline. He is the author of seven books and more than 100 journal articles and published abstracts. Todd A. Durham, MS, is Senior Director of Biostatistics and Data Management at Inspire Pharmaceuticals. Prior to joining Inspire, Mr. Durham served as Associate Director of Biostatistics at Quintiles, Inc. Mr. Durham has made significant statistical contributions to six NDA submissions and has been involved with five presentations to FDA advisory committees.
Book Details
ISBN-13: 9780470229644
Publisher: Wiley
Publisher Imprint: Wiley
Height: 236 mm
No of Pages: 500
Series Title: English
Weight: 840 gr
ISBN-10: 0470229640
Publisher Date: 03 Nov 2008
Binding: Hardback
Language: English
Returnable: Y
Spine Width: 25 mm
Width: 157 mm
User Reviews

Be the first to Write a Review on this book Integrated Cardiac Safety